Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR ...

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...

The global effort to combat climate change requires expanding renewable energy technologies. To optimise solar cells, ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

and a new instrument for individual ion mass spectrometry, which is being commercialized by biotechnology company Thermo Fisher Scientific. Kelleher and his collaborators call the resulting ...